シャドーイング練習: SVINutes: Pediatric Cerebrovascular Disease: Current Strategies, Future Directions - 動画で英語スピーキングを学ぶ
読み込み中...
1
Hello everyone, my name is Alhamza Albiadi, an Associate Professor of Neurology and Neurosurgery at the University of Pittsburgh School of Medicine.
2
I'm a Stroke Specialist and Neurointerventionist,
3
serve as the Director of Pediatric Neuroendrovascular Surgery and Surgical Co-Director of the Neurovascular Center of Excellence at Children's Hospital UPMC.
4
Today I'll be highlighting key concepts in pediatric cerebrovascular disease, current strategies, and where the field is heading.
5
This is an educational discussion and reflects my clinical judgment and experience.
6
So, the key principle is simple but critical.
7
Pediatric cerebrovascular disease is not adult in smaller bodies.
8
The causes are fundamentally different as children are dominated by arteriopathies like moya moya cardiac
9
and embolic sources genetic syndromes
10
and vascular malformations hemorrhagic strokes makes up almost half of pediatric
11
cases compared to only 10 to 15 in the adults
12
and their symptoms are subtle often non-focal
13
or seizure-like leading to diagnostic delays everything we do must focus not just on acute survival but on long-term neurodevelopmental trajectory.
14
In the acute ischemic setting, the biggest challenge we face is the recognition and time to diagnosis.
15
Dedicated pediatric stroke alerts and multidisciplinary mobilization dramatically improve the accuracy and workflow.
16
MRI with DWI and MRA remains our definitive tool to diagnosis of ischemia and assessing vessel status.
17
IV thrombolysis remains off-label, used selectively in adolescents who meet adult criteria at expert centers.
18
Endovascular thrombectomy is increasingly used for large vessel occlusion, with a growing evidence-based, showing feasibility and safety,
19
even though the data are largely extrapolated from adults.
20
Prevention must be tailored to etiology.
21
For instance, non-Moyomoy arteriopathy typically responds well to antiplatelet therapy.
22
Moyomoy disease, however, is unique.
23
Surgical revascularization with indirect bypass, EDAS, remains the most effective long-term neovascularization strategy.
24
For sickle cell disease, chronic transfusions are still the standard guided by TCD velocities.
25
And in children with cardiac disease or thrombophilias, long-term anticoagulation is often necessary.
26
Remember, each child requires individualized planning and multidisciplinary input.
27
Pediatric AVMs behave differently.
28
They are dynamic, can recruit new feeders, and can carry high lifetime risk of hemorrhage.
29
After rupture, the first phase is damage control, stabilizing the child, managing ICP, and addressing the hematoma.
30
Definitive AVM treatment is usually delayed until it's safe.
31
Our curative tools include microsurgery, which remains the gold standard for accessible lesions,
32
stereotactic radiosurgery for deep inaccessible AVMs, and targeted endovascular embolization as an adjunct.
33
When performing pre-operative embolization, precision is everything.
34
The key goal is to reduce the nitis size without compromising the venous drainage or normal perforators.
35
Vanum-gallon malformation is the benchmark of our neuroendovascular subspecialty.
36
These babies present critically with neonatal heart failure and pulmonary hypertension.
37
Older infants, however, may present with microcephaly or hydrocephalus.
38
Our treatment strategy is stage endovascular embolization, a controlled and gradual shunt reduction.
39
The goal is to relieve the life-threatening venous hypertension and allowing the cardiovascular system to recover.
40
Success relies on ultra-fine microcaptors, precise liquid embolics, and focal coiling of arteriovenous chuntings for controlled obliterations.
41
Our pediatric neuroendrovascular field also focuses on targeted therapeutics and functional testing.
42
Intraarterial chemotherapy for retinoblastoma, usually delivered through the ophthalmic artery, with remarkable vision-saving outcomes.
43
And for functional localization, the wider test still plays an important role in complex epilepsy or tumor cases,
44
helping map the language and memory dominance to avoid postoperative deficits.
45
Effective pediatric cerebrovascular care depends on a robust team.
46
Neurointervention, neurosurgery, pediatric vascular neurology, and pediatric critical care are the core of this team.
47
Supporting roles from cardiology, hematology,
48
genetics, rehab, and social work are essential in guiding etiology and long-term recovery.
49
These children needs both ongoing imaging surveillance and lifelong functional monitoring.
50
The future of pediatric neurovascular disease is precision-based.
51
Genomics, enhanced by endoluminal and liquid biopsy techniques,
52
are beginning to identify actionable mutations that might guide targeted non-surgical drug therapeutics.
53
Advanced imaging, such as vessel wall imaging, and 4D flow MRI is helping us visualize not just the anatomy,
54
but the underlying vascular physiology and hemodynamics that truly drive disease behavior.
55
As we look ahead, success isn't just recinalization or nidus obliteration.
56
It's restoring normal neurodevelopmental growth and function over lifetime.
57
Our mission is to protect the developing brain through multidisciplinary excellence and collaborative research.
58
Thank you for your time.
59
I look forward to ongoing discussions and collaborations.
60
Please feel free to reach out at any time.
61
Thank you you
このレッスンについて
「SVINutes: Pediatric Cerebrovascular Disease: Current Strategies, Future Directions」を使って、シャドーイングで英語を練習しましょう。
毎日15〜30分の練習で、IELTSスピーキングへの自信と実践的な英会話力が身につきます。
シャドーイングとは？英語上達に効果的な理由
シャドーイング（Shadowing）は、もともとプロの通訳者養成プログラムで開発された言語学習法で、多言語習得者として知られるDr. Alexander Arguelles によって広く普及されました。方法はシンプルですが非常に効果的：ネイティブスピーカーの英語を聞きながら、1〜2秒の遅延で声に出してすぐに繰り返す——まるで「影（shadow）」のように話者を追いかけます。文法ドリルや受動的なリスニングと異なり、シャドーイングは脳と口の筋肉が同時にリアルタイムで英語を処理・再現することを強制します。研究により、発音精度、抑揚、リズム、連音、リスニング力、そして会話の流暢さが大幅に向上することが確認されています。IELTSスピーキング対策や自然な英語コミュニケーションを目指す方に特におすすめです。